122.
The clinical characteristics of Asian patients with classical-type Hutchinson-Gilford progeria syndrome
by Sato-Kawano, Nanae
Journal of human genetics, 2017-12, Vol.62 (12), p.1031-1035

123.
Biological ageing and cardiovascular disease
by Samani, Nilesh J
Heart (British Cardiac Society), 2008-05, Vol.94 (5), p.537-539

124.
Two-Variance-Component Model Improves Genetic Prediction in Family Datasets
by Tucker, George
American journal of human genetics, 2015-11-05, Vol.97 (5), p.677-690

125.
Klotho G-395A gene polymorphism: impact on progression of end-stage renal disease and development of cardiovascular complications in children on dialysis
by Elghoroury, Eman A
Pediatric nephrology (Berlin, West), 2018-01-08, Vol.33 (6), p.1019-1027

126.
The value of cardiac genetic testing
by Ingles, Jodie
Trends in cardiovascular medicine, 2014, Vol.24 (6), p.217-224

127.
Kruppel-like factors in muscle health and disease
by Prosdocimo, Domenick A., PhD
Trends in cardiovascular medicine, 2015, Vol.25 (4), p.278-287

128.
Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide: Biomarkers for Mortality in a Large Community-Based Cohort Free of Heart Failure
by McKie, Paul M
Hypertension (Dallas, Tex. 1979), 2006-05, Vol.47 (5), p.874-880

129.
The impact of common gene variants on the response of biomarkers of cardiovascular disease (CVD) risk to increased fish oil fatty acids intakes
by Madden, Jacqueline
Annual review of nutrition, 2011-08-21, Vol.31 (1), p.203-234

130.
The Endocannabinoid System and Its Relevance for Nutrition
by MACCARRONE, Mauro
Annual review of nutrition, 2010, Vol.30 (1), p.423-440

131.
Population Structure, Admixture, and Aging-Related Phenotypes in African American Adults: The Cardiovascular Health Study
by Reiner, Alexander P
American journal of human genetics, 2005, Vol.76 (3), p.463-477

132.
Functional implications of single nucleotide polymorphisms rs662 and rs854860 on the antioxidative activity of paraoxonase1 (PON1) in patients with rheumatoid arthritis
by Mucientes, Arkaitz
Clinical rheumatology, 2018-12-26, Vol.38 (5), p.1329-1337

133.
New approaches to establish genetic causality
by McNally, Elizabeth M., MD, PhD
Trends in cardiovascular medicine, 2015, Vol.25 (7), p.646-652

134.
Cardiometabolic Correlates and Heritability of Fetuin-A, Retinol-Binding Protein 4, and Fatty-Acid Binding Protein 4 in the Framingham Heart Study
by Kaess, Bernhard M
The journal of clinical endocrinology and metabolism, 2012-10, Vol.97 (10), p.E1943-E1947

135.
Genetic loci associated with ideal cardiovascular health: A meta-analysis of genome-wide association studies
by Allen, Norrina B., PhD
The American heart journal, 2016, Vol.175, p.112-120

136.
Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD random...
by McCaffery, J
Diabetologia, 2015-05-14, Vol.58 (8), p.1803-1813

137.
Impact of oxidative stress during pregnancy on fetal epigenetic patterns and early origin of vascular diseases
by Ávila, Jose Guillermo Ortega
Nutrition reviews, 2015-01, Vol.73 (1), p.12-21

138.
Genetic loci associated with lipid concentrations and cardiovascular risk factors in the Korean population
by Park, Mi-Hyun
Journal of medical genetics, 2011-01, Vol.48 (1), p.10-15

139.
MicroRNAs Are Involved in End-Organ Damage During Hypertension
by Heggermont, Ward A
Hypertension (Dallas, Tex. 1979), 2012-11, Vol.60 (5), p.1088-1093

140.
Applied Pharmacogenomics in Cardiovascular Medicine
by Weeke, Peter
Annual review of medicine, 2014-01-14, Vol.65 (1), p.81-94
